Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma.

Sun, Yunfan; Wu, Liang; Zhong, Yu; Zhou, Kaiqian; Hou, Yong; Wang, Zifei; Zhang, Zefan; Xie, Jiarui et al. · Cell · 2021

basic_science · Level V

Where this comes from

Abstract

Hepatocellular carcinoma (HCC) has high relapse and low 5-year survival rates. Single-cell profiling in relapsed HCC may aid in the design of effective anticancer therapies, including immunotherapies. We profiled the transcriptomes of ∼17,000 cells from 18 primary or early-relapse HCC cases. Early-relapse tumors have reduced levels of regulatory T cells, increased dendritic cells (DCs), and increased infiltrated CD8<sup>+</sup> T cells, compared with primary tumors, in two independent cohorts. Remarkably, CD8<sup>+</sup> T cells in recurrent tumors overexpressed KLRB1 (CD161) and displayed an innate-like low cytotoxic state, with low clonal expansion, unlike the classical exhausted state observed in primary HCC. The enrichment of these cells was associated with a worse prognosis. Differential gene expression and interaction analyses revealed potential immune evasion mechanisms in recurrent tumor cells that dampen DC antigen presentation and recruit innate-like CD8<sup>+</sup> T cells. Our comprehensive picture of the HCC ecosystem provides deeper insights into immune evasion mechanisms associated with tumor relapse.

Medical subject headings